Suppr超能文献

[癌症患者皮肤对不同剂量舒多糖反应的临床研究]

[Clinical studies on the reaction of the skin to various doses of Su-polysaccharide in cancer patients].

作者信息

Sato M, Sakai K, Kimura S, Tamaki Y, Kiyasu Y, Joko Y, Ogoshi T

出版信息

Gan To Kagaku Ryoho. 1985 Feb;12(2):245-9.

PMID:3970550
Abstract

The reaction of skin to 10-micrograms and 20-micrograms quantities of Su-polysaccharide (Su-Ps) were examined in 117 patients with cancer, and the results obtained were as follows. Reaction was a little greater to the 20-micrograms dose than to the 10-micrograms dose, but the two parameters were much correlated with each other. The rates of patients showing positive reactions to each dose were 30.8% for 10-micrograms and 34.2% for 20-micrograms. The reactions were augmented by administration of OK-432. The augmentation of skin reaction by OK-432 was more prominent at 20-micrograms doses than at 10-micrograms doses, therefore appearing to be Su-polysaccharide dose-dependent. The ideal Su-polysaccharide dose for Su-Ps skin reaction thus seemed to be 20-micrograms.

摘要

对117例癌症患者的皮肤对10微克和20微克舒多糖(Su-Ps)的反应进行了检测,结果如下。对20微克剂量的反应比对10微克剂量的反应略大,但这两个参数相互之间密切相关。对每个剂量呈阳性反应的患者比例,10微克剂量组为30.8%,20微克剂量组为34.2%。通过注射OK-432可增强反应。OK-432对皮肤反应的增强在20微克剂量时比10微克剂量时更显著,因此似乎与舒多糖剂量相关。因此,用于舒多糖皮肤反应的理想舒多糖剂量似乎为20微克。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验